
Stock Price
2024-10-29
Market Capitalization
2024-10-29
Revenue
FY, 2026
| INR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 | FY, 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48.4B | 38.6B | 34.3B | 34.3B | 46.0B | 57.8B | 67.6B | 54.6B | 55.6B |
| Cost of goods sold | 2.3B | 23.6B | 21.9B | 1.9B | 1.6B | 5.3B | 6.1B | 4.4B | 38.1B |
| Gross profit | 49.6B | 15.3B | 12.6B | 32.7B | 44.6B | 52.5B | 61.5B | 50.2B | 17.6B |
| Gross profit margin, % | 102.5% | 39.6% | 36.6% | 95.4% | 97.1% | 90.9% | 91.1% | 91.9% | 31.6% |
| Operating expense total | 33.6B | 2.0B | 2.2B | 19.5B | 33.5B | 41.3B | 39.2B | 31.7B | 3.9B |
| Depreciation and amortization | 8.2B | 5.3B | 5.3B | 5.3B | 4.8B | 4.6B | 4.7B | 4.7B | 4.7B |
| EBITDA | 16.0B | 13.3B | 10.4B | 13.3B | 11.2B | 11.2B | 22.4B | 18.5B | 13.7B |
| EBITDA margin, % | 33.1% | 34.6% | 30.3% | 38.8% | 24.4% | 19.4% | 33.1% | 34.0% | 24.6% |
| EBIT | 7.4B | 9.5B | (6.4B) | 9.0B | 6.6B | 7.7B | 13.3B | 14.0B | 9.4B |
| EBIT margin, % | 15.3% | 24.7% | -18.6% | 26.1% | 14.3% | 13.4% | 19.7% | 25.6% | 16.9% |
| Interest income | 103.9M | 129.3M | 153.1M | 156.8M | 884.1M | 143.9M | 360.3M | 2.3B | 1.8B |
| Interest expense | 26.1B | 14.7B | 6.9B | 6.0B | 5.6B | 5.6B | 4.5B | 4.1B | 3.7B |
| Pre tax profit | (18.7B) | (5.1B) | (13.1B) | 4.0B | 3.1B | 2.3B | 12.5B | 12.2B | 7.5B |
| Income tax expense | (1.8B) | (1.4B) | 8.4B | 1.1B | 2.0B | 1.7B | 2.3B | 4.0B | 3.0B |
| Net Income | (16.9B) | (3.7B) | (21.5B) | 2.9B | 1.1B | 554.2M | 10.2B | 8.1B | 4.5B |
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |